SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetards Regulatory News (PEG)

Share Price Information for Petards (PEG)

Share Price is delayed by 15 minutes
Get Live Data
9.50    0.00 (0.00%)
Bid:
9.00
Ask:
10.00
Spread: 1.00 (11.111%)
Market Cap: £5.77m
PEG Live PriceLast checked at - London Stock Exchange

Intraday Petards Share Chart

Trading Statement

12 Jan 2018 07:00

RNS Number : 6685B
Petards Group PLC
12 January 2018
 

12 January 2018

 

 

PETARDS GROUP PLC

 ("Petards" or the "Group")

 

Trading Update

 

 

Petards, the AIM quoted developer of advanced security and surveillance systems, is pleased to provide an update on trading following the end of its financial year on 31 December 2017.

 

The Group's profit before tax for the year ended 31 December 2017 is expected to be above market expectations due to the positive net effect of exceptional items arising in the year. The Group expects to report 2017 revenues to be up year on year to £15.6 million. However, some delays in programmes to develop additional software functionality for eyeTrain systems has resulted in approximately £1 million of revenues being deferred into 2018. These relate to scheduled deliveries of both software and equipment and accordingly profit before tax from trading operations will be lower than previously expected.

 

Set against this, the 2017 results include two exceptional items. First, the Group has received and accepted an offer to settle a historic matter, unrelated to the current trading activities of the Group, which arose over ten years ago. Under the settlement the Group will receive a total of £702,000 in cash comprising an amount of £362,000 plus compensatory interest of £340,000. The Board considers this to be a very satisfactory outcome. The terms of the settlement preclude the Group from providing further details.

 

The second exceptional item is also unrelated to the current trading activities of the Group. The Board has decided that any future activities that the Group may undertake in the US will not be conducted through its present US subsidiary which has been dormant for several years. In accordance with International Accounting Standards, the £211,000 deficit on the Group's currency translation reserve will be reclassified from equity to income and shown as an expense. The reclassification has no impact on the Group's net assets or cash.

 

Raschid Abdullah, Chairman of Petards Group plc said:

 

"It was pleasing that in December we completed both the full conversion of the Group's £1,480,000 outstanding loan notes into Petards ordinary shares and have subsequently received the settlement of £702,000. As a result, the Group's balance sheet has been substantially strengthened with the removal of the loan note liability that was due for redemption in September 2018 and its cash resources have been increased this week following receipt of the £702,000.

 

While it is disappointing that delays in the development programmes for new eyeTrain products has deferred some revenues into 2018, the Group continues to trade profitably and enters 2018 with an order book of £18 million. Over £12 million of this is scheduled for delivery in the coming year and the Board remains confident of the Group's future prospects."

 

 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

Contacts:

 

 

Petards Group plc

www.petards.com

 

Raschid Abdullah, Chairman

Mb: 07768 905 004

 

 

 

 

WH Ireland Limited, Nomad and Joint Broker

www.whirelandcb.com

 

Mike Coe / Ed Allsopp

Tel: 0117 945 3470

 

 

 

 

Hybridan LLP, Joint Broker

www.hybridan.com

Claire Louise Noyce

 

Tel: 020 3764 2341

claire.noyce@hybridan.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDLAILLIT
Date   Source Headline
20th May 202612:07 pmRNSResult of AGM
20th May 20267:00 amRNS-RContract Win
23rd Apr 20267:00 amRNSPosting of Annual Report and Notice of AGM
15th Apr 20267:01 amRNSDirector Appointment
15th Apr 20267:00 amRNSFinal results for the year ended 31 December 2025
27th Mar 20267:00 amRNSContract Wins
13th Feb 20267:00 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSGrant of Share Options
5th Feb 20267:00 amRNSTrading Update
15th Dec 20257:00 amRNS-RDefence Order
2nd Dec 20259:00 amRNSNew Defence Contract Award
21st Nov 20257:00 amRNSContract extension
12th Nov 20254:41 pmRNSHolding(s) in Company
27th Oct 20259:00 amRNSRail Order Win
18th Sep 20257:00 amRNSInterim results
12th Sep 202510:51 amRNSNotice of Interim Results
12th Aug 20257:00 amRNS-RContract Win
6th Aug 202512:09 pmRNSResult of AGM
5th Aug 20257:00 amRNSMulti-year framework agreement renewal
29th Jul 20257:00 amRNS-RContract Renewal
30th Jun 20254:15 pmRNSPosting of Annual Report and Notice of AGM
24th Jun 20257:00 amRNS-RSaaS licensing renewal
23rd Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
10th Jun 202512:17 pmRNSHolding(s) in Company
9th Jun 20257:00 amRNS-RContract Win
28th May 20259:26 amRNS-RPetards Rail wins Alstom CSR Award
19th Mar 20258:39 amRNS-R‘Made in the North East’ Awards 2025
20th Feb 20257:00 amRNS-RContract Win
6th Feb 20253:33 pmRNSDirector/PDMR Shareholding
4th Feb 20254:49 pmRNSHolding(s) in Company
4th Feb 20254:45 pmRNSDirector/PDMR Shareholding
4th Feb 20259:33 amRNSDirector/PDMR Shareholding
30th Jan 20257:00 amRNSTrading Update
20th Jan 20257:00 amRNSDirectorate Change
14th Jan 20257:00 amRNSHolding(s) in Company
30th Sep 20247:00 amRNSInterim Results
25th Sep 20247:00 amRNSContract Win
24th Sep 202412:28 pmRNSContract Win
3rd Sep 20247:00 amRNSContract Wins
23rd Aug 20241:35 pmRNSContract Win
25th Jul 202411:33 amRNSResult of AGM
15th Jul 20247:00 amRNSChange of Adviser
24th Jun 20244:45 pmRNSPosting of Annual Report and Notice of AGM
14th Jun 20247:00 amRNSCompletion of Acquisition
13th Jun 20247:01 amRNSAcquisition
13th Jun 20247:00 amRNSFinal Results
23rd Feb 20247:00 amRNSHolding(s) in Company
19th Feb 20247:00 amRNSContract Win
14th Feb 20247:00 amRNSContract Extension
30th Jan 20247:00 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.